U.S. FDA Declines to Approve GSK Drugs Division ' s Long Acting HIV Injection U.S. FDA Declines to Approve GSK Drugs Division ' s Long Acting HIV Injection

GlaxoSmithKline ' s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news